Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).
If you understand the idea,π― press a thumb up! π Have a question? Don't be shy to ask! π€ Interested to study how to analyze charts, follow me!
If you understand the idea,π― press a thumb up! π Have a question? Don't be shy to ask! π€ Interested to study how to analyze charts, follow me!